BLRX - 1.20 Pre-market now at 1.25/1.26 BioLineRx Provides Update on Phase 2 Open-Label Study for BL-8040 as Novel Stem Cell Mobilization Treatment http://stockcharts.com/c-sc/sc?s=BLRX&p=D&b=5&g=0&i=t94671680470&r=1490012379898 http://stockcharts.com/c-sc/sc?s=BLRX&p=W&b=5&g=0&i=t85609551802&r=1490012360976